|
|
|
||||||||||
Research Articles |
A case of vancomycin-associated neutropenia occurring during long-term outpatient therapy with vancomycin is described. Pharmacokinetic studies demonstrated that the patient's vancomycin serum levels were within an acceptable range during treatment. Eighteen other reported cases of vancomycin-associated leukopenia are discussed in brief. An immunologic mechanism has been proposed but a clear understanding is lacking. Patients receiving long-term vancomycin therapy should have their white blood cell counts periodically monitored.
This article has been cited by other articles:
![]() |
M. Rybak, B. Lomaestro, J. C. Rotschafer, R. Moellering Jr., W. Craig, M. Billeter, J. R. Dalovisio, and D. P. Levine Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Am. J. Health Syst. Pharm., January 1, 2009; 66(1): 82 - 98. [Full Text] [PDF] |
||||
![]() |
M. Segarra-Newnham and S. S Tagoff Probable Vancomycin-Induced Neutropenia Ann. Pharmacother., November 1, 2004; 38(11): 1855 - 1859. [Abstract] [Full Text] [PDF] |
||||